Do peptides work?
"Do peptides work" sounds like a yes-or-no question, but it isn't one, because "peptides" isn't one thing. Some peptides are proven medicines with decades of human data behind them. Others are compounds that show up promising in a rat and nowhere near a controlled human trial. The honest answer depends entirely on which peptide, and for what, so that's how we'll walk through it.
Which peptides actually have proof they work?
A small group of peptides have been through the process that actually establishes whether something works: large, controlled human clinical trials, followed by FDA approval. Insulin is the oldest example, used for over a century to manage blood sugar in diabetes. Semaglutide and tirzepatide, the compounds behind Ozempic, Wegovy, Mounjaro, and Zepbound, are newer but went through extensive human trials before approval, and have "helped millions of people reach a healthier weight," according to Harvard Health Publishing.2 Tesamorelin, approved for a specific fat-redistribution condition, is another. For this group, "does it work" has a real, evidence-backed answer.
| Category | Do we know it works? |
|---|---|
| FDA-approved peptide drugs (insulin, semaglutide, tirzepatide, tesamorelin) | Yes, for their approved use. Backed by large human trials. |
| Studied-but-unapproved wellness peptides (BPC-157, CJC-1295, GHK-Cu, TB-500) | Unknown. Promising animal/lab data; almost no human trials. |
| Cosmetic peptides in skincare | Mixed. Some ingredients like collagen-stimulating peptides have modest supporting research.2 |
What about BPC-157, CJC-1295, and other wellness peptides?
This is where the "do peptides work" question usually starts, since it's these newer compounds driving the social-media buzz. The reality, per Harvard Health Publishing, is that "a handful of test tube and animal studies suggests that peptides like BPC-157, CJC-1295, and GHK-Cu might support injury recovery and wound healing" — but "large-scale human trials are needed to evaluate the efficacy and safety of certain peptides for specific functions before definitive claims can be made."2
The American Medical Association put a number on just how thin that human evidence is for the most-studied claim, recovery. Dr. Anthony C. Tam, a family and sports medicine physician with Henry Ford Health, told the AMA: "With these newer injections, the claim that's been studied the most relates to recovery. There was one human trial study involving about 10 to 12 people for knee pain recovery. The details were limited, but the results suggested there may be some promise in improving overall pain scores."3 One trial, a dozen people, one condition. That's the entire human evidence base for the most-researched claim in this category.
"When you're talking about peptides being promoted online, those health claims have not been vetted by any expert group, the FDA, or anyone else. The health claims are divorced from data."
— Dr. Pieter Cohen, Associate Professor of Medicine, Harvard Medical School, in Harvard Health Publishing (July 2026)
Why animal studies don't settle it
A compound working in a rat is a legitimate reason to study it further. It is not proof that it works the same way in a person. Rodent physiology, dosing, and healing mechanisms differ from human ones in ways that regularly cause promising animal results to fail in human trials. That gap is exactly why the FDA requires human clinical trials before approving a drug, and why the peptides that skipped that step, however good their animal data looks, remain unproven rather than proven.
Why "trending on social media" isn't evidence
Part of what makes "do peptides work" hard to answer is that popularity and proof travel on completely different timelines. A compound can go viral in weeks; a properly controlled human trial, with a large enough group of people to rule out placebo effect and measure real outcomes, typically takes years and real funding. Harvard Health Publishing opened its own peptide explainer by noting these compounds "are trending on social media," then spent the rest of the article separating that trend from what's actually been proven.2 Social proof and scientific proof aren't the same currency, and marketing tends to borrow the language of the second while only having the first.
There's also a subtler trap: a peptide having a real, measurable biological effect isn't the same as it "working" for the specific goal being marketed. Growth-hormone-releasing peptides genuinely raise growth hormone levels; that's measurable. Whether that translates into meaningfully better muscle growth, recovery, or anti-aging outcomes for the average healthy adult is the separate, larger question that the human trials haven't answered.
So, do peptides work?
- For their approved medical use, yes: insulin, semaglutide, tirzepatide, and tesamorelin have strong human evidence.
- For most wellness claims, unproven either way: BPC-157, CJC-1295, GHK-Cu, and similar compounds have encouraging early research but essentially no large human trials confirming benefit.
- "Might work in a person" is not the same as "works," no matter how the product is marketed.
If you're weighing whether to try one, the more useful question than "do peptides work" is "does this specific peptide have human evidence for my specific goal," which is exactly what a licensed physician can help you sort through. Our BPC-157 deep dive walks through one example in full, and are peptides safe covers the separate question of risk.
Sources
- U.S. Food & Drug Administration — approved drugs and guidance on compounded/unapproved peptides.
- Harvard Health Publishing — "Peptides: what they are, potential benefits, and safety concerns."
- American Medical Association — "What doctors want patients to know about injectable peptides."